Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Prognostic and predictive valu...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis

Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis

Bibliographic Details
Main Authors: Shrimanker, R, Keene, O, Hynes, G, Wenzel, S, Yancey, S, Pavord, I
Format: Journal article
Language:English
Published: American Thoracic Society 2019
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma
    by: Shrimanker, R, et al.
    Published: (2018)
  • Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
    by: Price, D, et al.
    Published: (2019)
  • Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
    by: David B. Price, et al.
    Published: (2019-08-01)
  • Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma
    by: Jiang-Hua Li, et al.
    Published: (2021-08-01)
  • Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
    by: Howell, I, et al.
    Published: (2024)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs